Heart rate variability as an indicator of left ventricular systolic dysfunction

Cardiovascular Journal of Africa

Volumn 20, Issue 5, 2009, Pages 278-283

  Shehab, Abdullah ^a,b   Elnour, Asim A ^b   Struthers, Allan D ^c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART RATE VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; VASCULAR DISEASE;

AGED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; STROKE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70450205136     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 1998; 98(15): 1510-1516. (Pubitemid 28481667)
2. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79(12): 1645-1650. (Pubitemid 27339475)
3. Aronson D, Mittleman MA, Burger AJ. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 2004; 93(1): 59-63. (Pubitemid 38022034)
4. Lakusić N, Mahović D, Babić T, Sporis D. Changes in autonomic control of heart rate after ischemic cerebral stroke. Acta Med Croatica 2003; 57(4): 269-273. (Pubitemid 37356276)
5. Schwartz PJ, Rovere MT LA. ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Eur Heart J 1998; 19: 1593-1595.
6. Thompson R, John P. Heart Rate variability following ischemic stroke. Stroke 1999; 30: 2238-2248.
7. Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllylä VV. Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke. Stroke 1997; 28: 2150-2154. (Pubitemid 27497914)
8. Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllylä VV. Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction. Stroke 1996; 27: 2059-2063. (Pubitemid 26372581)
9. Adams HP (jun), del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38(5): 1655-1711. (Pubitemid 46691097)
10. Talman WT. Cardiovascular regulation and lesion of the central nervous system. Ann Neurol 1985; 18: 1-12. (Pubitemid 15025406)
11. Oppenheimer SM, Cechetto DF, Hachinski VC. Cerebrogenic cardiac arrhythmias: Cerebral electrocardiographic influences and their role in sudden death. Arch Neurol 1990; 47: 513-519.
12. Naver HK, Blomstrand C, Wallin BG. Reduced heart rate variability after right-sided stroke. Stroke 1996; 27: 247-251. (Pubitemid 26044495)
13. Yee KM. Can drug effects on mortality in heart failure be predicted by any surrogate measure? Eur Heart J 1997; 18: 1860-1864.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
15. Hedman AE, Hartikainen JEK. Has non-linear analysis of heart rate variability any practical value? Cardiac Electrophysiol Rev 1999; 3(4): 286-289.
16. Choudhury RP, Francisco Leyva. C-reactive protein, serum amyloid a protein, and coronary events. Circulation 1999; 100; e65.
17. Zuanetti G, De Ferrari GM, Priori SG, Schwartz PJ. Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 1987; 61(3): 429-435. (Pubitemid 17145949)
18. Al Suwaidi J, Shuichi H, Stuart T, Rick AN, David RH (jun), Amir L. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954. (Pubitemid 30131694)
19. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR. Endothelial function in congestive heart failure. Am Heart J 1993; 126: 761-764. (Pubitemid 23264855)
20. Hisako T, Martin GL, Ferdinand JV, Emily SM, Jane CE, Charles LF, et al. Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study. Circulation 1996; 94: 2850-2855.
21. Fauchier L, Dominique B, Pierre C. Jean Paul F. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999; 33: 1203-1207.
22. Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing DJ. Heart-rate variability in patients with ventricular arrhythmias - Effects of antiarrhythmic drugs. J Am Coll Cardiol 1991; 17: 604-612.
23. Coumel P, Hermida JS, Wennerblom B, Leenhardt A, Maisonblanche P, Cauchemez B. Heart rate variability in left ventricular hypertrophy and heart failure, and the effects of beta-blockade: A non-spectral analysis of heart rate variability in the frequency domain and in the time domain. Eur Heart J 1991; 12(3): 412-422;
24. Binkley PF, Haas GJ, RC Starling, Nunziata E, Hatton PA, Leier CV, et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993; 21: 655-661. (Pubitemid 23076283)
25. Flapan AD, Nolan J, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 1992; 67: 482-485.
26. John ES, Skiva KWC, Gabriel Y, Leata YCY, Kam WC, Kenneth Raymond, et al. Beta-blockade in heart failure. A comparison of carvedilol with metoprolol. J Am Coll Cardiol 1999; 34: 1522-1528. (Pubitemid 29528667)
27. The Digitalis Investigation Group (DIG). The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.
28. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-1389.
29. Pehlivanidis A. Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease. Atherosclerosis 2001; 157 (2): 463-469. (Pubitemid 32710027)